Clinical Trial Update: Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia

View source ↗

Summary

Clinical trial evaluating Placental Protein 13, serum endoglin, and uterine Doppler indices as predictors of preeclampsia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: Cairo University | Conditions: Preeclampsia | Status: COMPLETED